Login
$CLPT
$8.26 -$0.04 (0.48%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Joseph M. Burnett Also a director
Chief Executive Officer and President
49 Not stated Not stated $2,814,944
Danilo D’Alessandro
Chief Financial Officer
41 Since 2021
5 years
2020 $1,254,353
Jeremy L. Stigall
Chief Business Officer
43 Since 2024
2 years
2020 $1,122,803

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 10, 2026 · updated by the 8-K of May 21, 2026

Directors
8
serving now
Independent
6 of 6
stated in the proxy; 2 not stated
Average tenure
7.6 years
from year joined
CEO also chairs the board
No
R. John Fletcher
Director Age On board Independent Committees Other public boards 2025 pay Source
R. John Fletcher
80 2017
9 years
Independent
Audit Committee Corporate Governance and Nominating Committee · Chair
KORU Medical Systems (Nasdaq: KRMD) $242,645
Joseph M. Burnett
49 2017
9 years
Not stated None stated None stated Paid as CEO
Lynnette C. Fallon
66 2021
5 years
Independent
Audit Committee · Chair Corporate Governance and Nominating Committee
None stated $219,997
B. Kristine Johnson
74 2019
7 years
Independent
Compensation Committee · Chair
Atricure, Inc. (Nasdaq: ATRC) $207,497
Matthew B. Klein
54 2020
6 years
Not stated None stated None stated $192,497
Linda M. Liau
59 2021
5 years
Independent
Compensation Committee
None stated $199,997
Timothy T. Richards
68 2014
12 years
Independent
Compensation Committee Corporate Governance and Nominating Committee · Chair
None stated $212,300
Pascal E.R. Girin Leaving at the meeting
Not stated Not stated Independent
Audit Committee
None stated $202,638

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 10, 2026
PTC Therapeutics, Inc.
Dr. Klein, one of our directors, is PTC's Chief Executive Officer and President
$2.8 million and $2.9 million
2024 and 2025

Supply Agreement under which the company provides PTC with hardware, software, clinical case support and market development services; PTC made payments to the company under it

With Company Open in proxy
PTC Therapeutics, Inc.
Dr. Klein, one of our directors, is PTC's Chief Executive Officer and President
$10 million
January 2020 until August 2024

PTC held secured convertible notes issued by the Company

With Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support